FB pixel

Outstanding shares of BIO-key’s preferred stock converted into common stock


BIO-key International announced today that all remaining outstanding shares of the company’s Series A-1 and Series B-1 convertible preferred stock, and all accrued and unpaid dividends, have been converted into common stock at a conversion price of $3.60 per share.

As a result of these and other preferred stock conversions earlier in 2018, the New Jersey-based biometrics solutions provider has eliminated approximately $638,000 in future annual preferred stock dividends payments. BIO-key has also satisfied payment of all accrued preferred stock dividends through the issuance of common stock at a price of $3.60 per share.

In 2018, BIO-key has paid $828,441 in accrued preferred stock dividends through the issuance of 230,123 shares of its common stock. Reflecting the preferred stock conversions and accrued dividend payments in 2018, BIO-key has issued 4,885,569 shares of common stock, increasing its total issued and outstanding shares to 12.6 million.

“We are grateful for the support and confidence of these long-term investors who converted preferred stock and accrued dividends into common stock at roughly a 61% premium to the Friday June 1st closing price of $2.23,” commented BIO-key’s CEO Michael DePasquale. “The conversions simplify and strengthen BIO-key’s capital structure while eliminating all future dividend payment requirements.”

Related Posts

Article Topics

 |   | 

Latest Biometrics News


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The ID16.9 Podcast

Most Read This Week

Featured Company

Biometrics Research

Biometrics White Papers

Biometrics Events

Explaining Biometrics